treatment of Pseudomonas infections. Resistance genes such as MBLs can easily be tramsitted by genomic compartments shuch as plasmids and calss I integrons, and this may be a source of dissemination of antibiotic resistance throughout the clinics. 8, 9 MBLs can intensely hydrolyze all betalactam antibiotics except azetreonam. These enzymes need zinc as cofactor. 10 Sulbactam, tazobactam, and clavulanic acid which are often used to inhibit betalactamase enzymes are not useful against MBLs. 11, 12 Due to our limitation in providing efficient antibiotic alternatives in cases of resistant organisms, the presence of MBL in clinical isolates of P. aeruginosa were investigated. In addition, prolonged hospitalization and high fatality rates have been associated with MBL positive P. aeruginosa infections. The aim of this study was to investigate the antibiotic resistance profile and the prevalence of blaVIM-1, blaVIM-2 and blaSPM-1 genes encoding MLBs among clinical isolates of P. aeruginosa obtained from Afzalipour and Bahonar hospitals of Kerman city, by double disk synergy test (DDST) and multiplex polymerase chain reaction (PCR).
Methods
In the present cross-sectional study, 60 suspected isolates of Pseudomonas were collected out of 234 examined isolates obtained from hospitalized patients in Kerman, Iran, during 2014-2015. These bacteria had been recovered from several nosocomial samples such as urine, wound, blood, trachea and other clinical samples. The colonies were again cultured in MacConkey agar medium and pure colonies were recognized as P. aeruginosa according to Gram staining and bacteriological tests such as oxidase, catalase, oxidative-fermentative test, growth on media such as TSI, SIM, cetrimide agar (Merk, Germany) and growth at 42°C. Isolates were conserved in Trypticase soy broth media (TSB) including 20% glycerol and stored at -70°C until use. 13 Antibiotic Susceptibility Tests Disk diffusion assay (Kirby-Bauer) on Muller-Hinton agar plates (Merck, Germany) was accomplished with the antibiotic susceptibility test according to the Clinical & Laboratory Standards Institute (CLSI).
14 The antimicrobial disks used (Mast Co, UK) are shown in Table 1 . Pseudomonas aeruginosa ATCC27853 was applied as a control strain for the susceptibility testing. DDST was applied for phenotypic examination of MBLs. Therefore, 0.5 M EDTA solution was prepared using 186.1 g of disodium EDTA. H2O2 was dissolved in 1000 mL distilled water (pH 8.0 which was adjusted by addition of NaOH). Then, 930 μg of this solution was appllied on imipenem disk and incubated to be dried. These disks were then placed on a plate of Muller-Hinton agar with cultured P. aeruginosa. After an incubation period of 16-18 hours at 37°C, a positive result for MBL expression was considered as a diameter equal or greater than 7 mm of IMP-EDTA disk respective to the imipenem disk. DNA Extraction and PCR Reaction For DNA extraction, boiling assay was used. Colonies were extracted from cetrimide agar and were incubated at 37 ∘ C for 16 hours. The bacterial precipitate was dissolved in 500 L distilled water, and the bacteria in the mixture were heated at 100 ∘ C for 10 minutes, and then centrifuged at 13 000×g (10 minutes, room temperature). The supernatant containing DNA was collected into a new micro tube. 12 PCR reaction for diagnosis of MBL genes was accomplished in Mastercycler Eppendorf (Eppendorf, Germany) and in final volume of 25 L including PCR Buffer (10x, 2.5 L) (CinnaGen, Iran), MgCl 2 (50mM, 1 L) (CinnaGen, Iran), dNTPs (10mM, 1 L) (CinnaGen, Iran), forward and reverse primers (10 pmol/ L, 1 L each), Taq DNA polymerase (50 U/ L, 1 L) (CinnaGen, Iran), DNA (2 L), and distilled water (15.5 L). P. aeruginosa PO510 (Pasargad Research Laboratory) producing blaVIM-1 and P. aeruginosa 16 producing blaSPM-1 were applied as the positive controls, while P. aeruginosa ATCC 27853 served as the negative control. The amplicons were analyzed by 1% (w/v) agarose gel electrophoresis and stained with ethidium bromide and visualized on gel documentation (Bio Rad، USA) (Figure 1 ). Primer sequences were designed using the NCBI Primer BLAST database. Primers sequences used for detection of MBL genes and PCR temperature profile for amplification of MBL genes are shown in Tables 2 and 3 , respectively. For the statistical analyses, SPSS software version 19.0 was applied.
Results
The samples were taken from urine (n = 24, 40%), blood (n = 4, 6.6%), wound (n = 9, 15%), tracheal aspirate (n = 12, 20%), and other sources (n = 11, 18.3%). Thirty-three (66.66%) out of 60 isolates were multidrug resistant (MDR). PCR analysis was performed for all the P. aeruginosa iso lates. The isolates demonstrated major resistance to carbencillin (73.3%), tobramycin (78.3%), and cefotizoxime (75%) ( 
Discussion
Carbapenems are effective β-lactam antibiotics for drastic cure of infections caused by Gram-negative bacteria. 15 Among β-lactamases, imipenem is the chosen antibiotic for fighting against this bacterium, however P. aeruginosa can disintegrate this antibiotic through MBL enzyme. 16 The rate of imipenem-resistant isolates (46.4%) in our study indicated a menace regarding therapy alternatives in our clinics. Imipenem and meropenem are commonly used antibiotics for the treatment of hospital-acquired infec tions; nevertheless, enhanced resistance against these agents has restricted their success. 17 In our results, among 28 imipenem-resistant strains, 17 (60.7%) were positive for production of MBL as shown by DDST. Kalantar et al 18 exhibited that 22% of the imipenem-resistant P. aerugi nosa isolates were MBL-positive and 8 strains (8%) were positive for blaVIM1 as proved by PCR. Sarhangi 21 The variation seen between the results of our study and those of the previous reports may be due to the diversity in geographical areas, diversity in sorts of the diseases, the increased consumption of antibiotics, or diversity in antibiotic treatment abstinence. Some MBL encoding genes have been mapped as mobile genes with possibility of transmission between organisms. 16 The most prevalent, introduced families are IMP, VIM, GIM, SPM, and SIM. 1 In our study, 60.7% of the total 60 P. aeruginosa isolates were MBL producer, which were more than the outbreak of MBL producers in Egyptian studies (27% and 32.3%) and Indian study (28.57%). 1 VIM enzymes were also most prevalent in Korea (88%) and Greece (85%). 22 Previous studies demonstrated that IMP and VIM producer genes of MBLs were also common in Asian studies. [23] [24] [25] VIM type was also highly prevalent in Turkey. 26 In previous studies in Egypt and Taiwan, VIM-2 demonstrated the highest outbreak among imipenem-resistant P. aeruginosa strains. 1, 27 Since most of the integrones harbored VIM-1 gene code for aminoglycosides destructing enzymes, the matter is of clinical importance. 28 In the present study, SPM was the commonest (28.5%) gene detected among imipenem-resistant P. aeruginosa isolates. The other MBL genes were not identified. MBL producer imipenem resistant isolates that were negative for the MBL genes may benefit from other resistant genes like IMP, SIM, NDM GIM or other resistance mechanisms to carbapenem. Identifying the MBL non-producer isolates with DDST that expressed the MBL genes may indicate low sensitivity of our phenotyoic assay. The imi-penem resistant isolates negative for MBL genes may also have other mechanisms associated with carbapenem resistance (such as AmpC β-lactamase expression, or using membrane efflux pathways). SPM is a widespread MBL gene among the P. aeruginosa strains; nevertheless, other low frequency enzymes have also been detected. [29] [30] [31] [32] SPM carbapenemase represents a major mechanism responsible for resistance to ceftazidime on ceftazidime-resistant P. aeruginosa isolates. 30 Zavascki et al identified 86 MBL producing strains, 16 .27% of which expressed the blaSPM gene, 33 and Graf et al also discovered the blaSPM gene in 13.51% strains that were only susceptible to polymyxin B. 34 Our data are in accordance with these studies regarding high prevalence of SPM among P. aeruginosa isolates. The results of Moosavian et al study on 122 imipenem resistant P. aeruginosa isolates showed that only 2 isolates (1.6%) contained blaVIM-2 gene, whereas none of them were positive for blaSPM-1. 13 Sarhangi et al 19 discovered that 12.1% of imipenem-resistant P. aeruginosa isolates expressed blaVIM-2 gene, while no occurrence of blaSPM1 was found. In the study of Ghamgosha et al, 35 77.7% of MBL producing P. aeruginosa had VIM-1 gene, with no SPM-1 gene detected. Concurrent resistance to imipenem and meropenem may propose carbapenem resistance mechanisms other than the enzymatic pathway (such as porin loss and/or upregulation of efflux pumps). 30 High resistance to carbapenems and ceftazidime has been conferred to MBL production. 36 Current studies corroborate this propensity. 29, 30, 37, 38 Resistance to other antimicrobial agents has decreased the alternative treatments for managing multidrug-resistant P. aeruginosa. 38, 39 Widespread strains of the drug-resistant P. aeruginosa strains express either IMP or VIM-type genes that encode MBL. These are significant general health issues menacing the success of antimicrobial chemotherapy. The limitation of this study was low number of the isolated P. aeruginosa strains compared to some other studies, and the strength was the use of DDST and molecular detection of the isolates.
Conclusion
We propose applying powerful superintendence and intransigent infection controlling strategies to control infectious diseases. A controlled antibiotic usage should be considered to prevent the distribution of antibiotic resistance genes among hospital pathogens.
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